Capital expenditure increased 36.1%
Capital expenditure changed +36.1% from the comparable as-filed period.
$108.0M→$147.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HWM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current ratio decreased 21.0%
Current ratio changed -21.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
2.35→1.864 prior comparisons
Debt / revenue moved 1172 bp higher
Debt / revenue changed +1172 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
152.66%→164.37%2 prior comparisons
Inventory increased 7.0%
Inventory changed +7.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.0B→$2.1B4 prior comparisons
Working capital decreased 13.5%
Working capital changed -13.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2B→$1.9B4 prior comparisons
Current assets increased 7.7%
Current assets changed +7.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.8B→$4.1B4 prior comparisons
Selling, general & administrative increased 20.0%
Selling, general & administrative changed +20.0% from the comparable as-filed period.
$100.0M→$120.0M2 prior comparisons
Capex / revenue moved 27 bp higher
Capex / revenue changed +27 basis points from the comparable as-filed period.
5.17%→5.44%2 prior comparisons
Shares outstanding decreased 1.1%
Shares outstanding changed -1.1% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
402,062,262→397,660,4908 prior comparisons
Research & development increased 10.0%
Research & development changed +10.0% from the comparable as-filed period.
$10.0M→$11.0M2 prior comparisons
Operating cash-flow margin moved 81 bp higher
Operating cash-flow margin changed +81 basis points from the comparable as-filed period.
25.42%→26.23%2 prior comparisons
Free-cash-flow margin moved 54 bp higher
Free-cash-flow margin changed +54 basis points from the comparable as-filed period.
20.25%→20.79%2 prior comparisons
Receivables / revenue moved 103 bp lower
Receivables / revenue changed -103 basis points from the comparable as-filed period.
42.32%→41.29%2 prior comparisons
Operating cash flow / net income decreased 9.3%
Operating cash flow / net income changed -9.3% from the comparable as-filed period.
1.38→1.252 prior comparisons
R&D / revenue moved 7 bp lower
R&D / revenue changed -7 basis points from the comparable as-filed period.
0.48%→0.41%2 prior comparisons
Current long-term debt unchangedd 0.0%
Current long-term debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.0M→$1.0M4 prior comparisons
Selling, general & administrative increased 66.3%
Selling, general & administrative changed +66.3% from the comparable as-filed period.
$89.0M→$148.0M2 prior comparisons
Debt / revenue moved 1802 bp higher
Debt / revenue changed +1802 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
158.69%→176.72%2 prior comparisons
Current long-term debt decreased 80.0%
Current long-term debt changed -80.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$5.0M→$1.0M4 prior comparisons
Working capital decreased 9.9%
Working capital changed -9.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$2.1B→$1.9B4 prior comparisons
Capex / revenue moved 89 bp lower
Capex / revenue changed -89 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.97%→4.08%2 prior comparisons
Free-cash-flow margin moved 205 bp higher
Free-cash-flow margin changed +205 basis points from the comparable as-filed period.
16.76%→18.81%2 prior comparisons
Receivables / revenue moved 242 bp lower
Receivables / revenue changed -242 basis points from the comparable as-filed period.
43.25%→40.83%2 prior comparisons
Shares outstanding decreased 1.1%
Shares outstanding changed -1.1% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
403,126,322→398,801,3998 prior comparisons
Operating cash-flow margin moved 117 bp higher
Operating cash-flow margin changed +117 basis points from the comparable as-filed period.
21.72%→22.89%2 prior comparisons
Research & development decreased 11.1%
Research & development changed -11.1% from the comparable as-filed period.
$9.0M→$8.0M2 prior comparisons
Cash & equivalents increased 3.3%
Cash & equivalents changed +3.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$545.0M→$563.0M4 prior comparisons
Capital expenditure increased 2.0%
Capital expenditure changed +2.0% from the comparable as-filed period.
$102.0M→$104.0M3 prior comparisons
R&D / revenue moved 12 bp lower
R&D / revenue changed -12 basis points from the comparable as-filed period.
0.44%→0.31%2 prior comparisons
Operating cash flow / net income decreased 0.4%
Operating cash flow / net income changed -0.4% from the comparable as-filed period.
1.1→1.092 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.